You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Life & Medical Care

Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Market Study 2016-2026, by Segment (XmAb-7195, BI-1206, … …), by Market (Hospital, Clinic, … …), by Company (BioInvent International AB, MacroGenics, Inc., … …)

Summary

The global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
XmAb-7195
BI-1206
MGD-010
SM-201
Others
Demand Coverage (Market Size & Forecast, Consumer Distribution):
Hospital
Clinic
Others
Company Coverage (Sales data, Main Products & Services etc.):
BioInvent International AB
MacroGenics, Inc.
Shire Plc
Xencor, Inc.
Major Region Market
North America
Europe
Asia-Pacific
South America
Middle East & Africa
Table of Content
1 Industry Overview
1.1 Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Industry
1.1.1 Overview
1.1.2 Products of Major Companies
1.2 Market Segment
1.2.1 Industry Chain
1.2.2 Consumer Distribution
1.3 Price & Cost Overview
2 Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Market by Type
2.1 By Type
2.1.1 XmAb-7195
2.1.2 BI-1206
2.1.3 MGD-010
2.1.4 SM-201
2.1.5 Others
2.2 Market Size by Type
2.3 Market Forecast by Type
3 Global Market Demand
3.1 Segment Overview
3.1.1 Hospital
3.1.2 Clinic
3.1.3 Others
3.2 Market Size by Demand
3.3 Market Forecast by Demand
4 Major Region Market
4.1 Global Market Overview
4.1.1 Market Size & Growth
4.1.2 Market Forecast
4.2 Major Region
4.2.1 Market Size & Growth
4.2.2 Market Forecast
5 Major Companies List
5.1 BioInvent International AB (Company Profile, Sales Data etc.)
5.2 MacroGenics, Inc. (Company Profile, Sales Data etc.)
5.3 Shire Plc (Company Profile, Sales Data etc.)
5.4 Xencor, Inc. (Company Profile, Sales Data etc.)
6 Conclusion